- Home
- NRIX vs NSIT Comparison
NRIX vs NSIT Comparison
Compare NRIX & NSIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRIX | NSIT |
|---|---|---|
| Founded | 2009 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | NRIX | NSIT |
|---|---|---|
| Price | $17.75 | $107.10 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 4 |
| Target Price | $30.50 | ★ $116.25 |
| AVG Volume (30 Days) | ★ 874.4K | 570.8K |
| Earning Date | 04-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.97 |
| Revenue | $76,987,000.00 | ★ $8,247,180,000.00 |
| Revenue This Year | N/A | $3.79 |
| Revenue Next Year | $48.05 | $2.16 |
| P/E Ratio | ★ N/A | $106.29 |
| Revenue Growth | ★ 99.31 | N/A |
| 52 Week Low | $8.20 | $63.62 |
| 52 Week High | $22.50 | $148.36 |
Technical Indicators
Market Signals| Indicator | NRIX | NSIT |
|---|---|---|
| Relative Strength Index (RSI) | 63.12 | 83.34 |
| Support Level | $17.21 | $105.78 |
| Resistance Level | $19.98 | $111.54 |
| Average True Range (ATR) | 0.80 | 4.28 |
| MACD | 0.17 | 1.91 |
| Stochastic Oscillator | 88.45 | 97.04 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About NSIT Insight Enterprises Inc.
Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, government agencies, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital workplace, cloud/data center transformation, IT modernization, Cyber Security and supply chain optimization solutions and services.